Population | People living in sub-Saharan Africa |
---|---|
Intervention | No intervention |
Comparison | No comparison; prevalence stratified by population characteristics will be extracted |
Outcome | Confirmed presence of virus or antibodies for EBOV, SUDV, BDBV, TAFV, RESTV, MARV, or RAVV, as measured by either viral testing (e.g., RT-PCR) or antibody testing (e.g., ELISA) |
Study Design | Cross-sectional studies, cohort studies, and randomized controlled trials; no case studies or case–control studies |